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ABSTRACT 
Coconut oil has been one of the most widely used vegetable oils since the agricultural revolution. 
Only in recent years has there been controversy over the desirability of its use. Controversy has usually 
stemmed from observed disturbances of calcium or cholesterol metabolism when hydrogenated coconut 
oil was fed, frequently with inadequate linoleate supplementation, to experimental animals. Furthermore, 
in many of the studies involving cholesterol, entirely unphysiological amounts of cholesterol have been 
included in the diet. It is contended here that the findings in such studies are the consequence of abnor­
mal nutrition rather than inherent defects in coconut oil. Evidence from epidemiological studies of arte­
riosclerosis in populations consuming large amounts of coconut oil are cited to show that coconut oil 
in a natural diet is not dis-advantageous and may even be of advantage. The high level of medium chain 
~ fatty acids in coconut oil is discussed from the point of view that they may contribute to beneficial effects 
on the part of coconut oil under some abnormal conditions. 
The coconut palm grows so easily in tropical climates oh sandy soil near the ocean and is so useful 
to humans that it has replaced other vegetation in large areas since prehistoric times (1-3). However, 
this development has had its dangers to evolutionary ecology. Each of the several million trees in existence 
in India, Malaysia, China and the Philippines may yield 1-2 gal of coconut oil annually for a total produc­
tion of several million metric tons providing the main fat intake and a large part of the calorie require­
ments for a large area of our planet. 
The rise in population and concomitant increasing demands for sources of dietary fats have made 
it un urgent problem to consider whether the nutritional properties of coconut oil are such that its produc­
tion should be expanded or whether the consumption of other easily grown oils should be recommended. 
One could have expected that the mass nutritional experiment which has been under way with coconut 
oil for so many thousand years would have settled the question of its desirability compared to other oils; 
indeed, no objections to its use were raised until a few decades ago. At present, the somewhat vague ideas 
on the relationship of so-called saturated fats to arterio-sclerosis have raised some doubts about the 
usefulness of this oil. This has been particularly true since the introduction of hydrogenated coconut 
oil and its administration to experimental animals in purified diets. 
On reviewing the nutritional work with coconut oil, one is overwhelmed by the magnitude of work 
that has been carried out and at the same time by the confusion and contradictions existing in relation to 
such topics as the occurrence of vascular lesions (so-called experimental atherosclerosis), cholesterol 
and calcium metabolism. 
Because of the vastness of the literature on coconut oil, one can at best recognize the barest outlines 
of the many problems connected with the nutritional aspects of this fat. However, a review of pertinent 
material may focus attention at some existing contradictions and may help to clarify them. 
Some of the chemical properties of coconut oil are uniquely different from those of other dietary 
fats and oils. Table I shows that about 80% of the constituent fatty acids of the triglycerides of coconut oil 
have a chain length of fewer than 16 carbon atoms. Laurate accounts for nearly half of the fatty acids. 
* Reproduced from the Journal of the American Oil Chemists' Society, Vol. 47, No. 10, with kind per­
mission of the author and the editor. 
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Except for other palm kernel oils, these acids occur in other dietary fats only in trace amounts; 
only butter contains 10-25% of short or medium chain length fatty acids. The many differences in the 
metabolic fate of these fatty acids compared to those having carbon chains of 16 or more have been 
repeatedly reviewed (4,5). Triglycerides containing the shorter acids hydrolyze more easily, and the 
shorter the acids, the higher is the percentage directly absorbed by the blood vessels rather than the 
lymph circulation. Most of the acids with carbon chain length of less than 12 are a ready source of energy 
in that they are rapidly converted into CO2 (6); only traces are deposited in mammalian tissues. 
Considerable interest has centered around the problem as to whether the high laurate content of 
coconut oil is biologically advantageous. Doubts are sometimes expressed because of adverse effects in 
experiments in which ethyl laurate is. fed to rats (7). Such experiments are£ not pertinent to the question 
of whether triglycerides containing laurate are biologically advantageous not only because the nutritional 
effects of ethyl esters cannot be compared with those of triglycerides but particularly because such ex­
periments often have been carried out with purified, essential fatty acid deficient diets. When glyceryl-
trilaurate was fed to rats in the presence of methyl linoleate, no abnormal effects were noted (8). At 
present, no work has been reported suggesting untoward effects in mammalians fed laurate-containing 
triglycerides in the presence of linoleate. 
Caprylic acid (Cs), which is most readily metabolized by the liver (9), was found to have rather 
specific metabolic effects. Its feeding to rats strongly counteracted signs of vitamin B deficiency (1.0); 
its application reduced the carbon clearance time in rats suggesting that caprylate stimulates the RES 
(11,12). Such effects gradually decreased as the chain length of the fatty acids increased. 
Coconut oil triglycerides are characterized by a high laurate content in the beta position (13). 
This fact should be kept in mind because the retention of the laurate in the~2 position during absorption 
may be important (14). 
The delicate liquid filling the immature coconut (coconut milk), which eventually turns into the 
lipid rich meat of the ripened fruit contains a large variety of pharma-cologically active substances. 
There is voluminous literature about growth factors for plant seeds (15, 16), materials preventing senes­
cence of wheat leaves (17), etc. These materials probably deserve the nutritionists' attention because 
current work suggests that differences in the effects of dietary fats may be due to the action of minor 
constituents. It has been reported that feeding of coconut oil to lactating cows enhances the fat content 
of the milk (18). 
Information about the effects of coconut oil on such general parameters as mortality and morbi­
dity is extremely sketchy. Attempts to evaluate these factors in wide human populations have proved 
to be a hopeless task. In one study on mice (19) the animals fed coconut oil lived longer than the controls 
fed safflower oil. In this laboratory, a long term study is being carried out on the survival rates of groups 
of 80 male rats of the Charles River strain which have been fed, from the time of weaning, various dietary 
fats supplied at level of 20% in a purified diet (20). When the hydrogenated coconut oil diet was sup­
plemented with 0.5% of a linoleate concentrate containing about 75% of linoleic acid, 17 of 80 animals 
died during the first year. When, at the end of the first year, the linoleate concentrate was raised to 1.5% 
of the diet (or 7.5% of the hydrogenated coconut oil), the mortality among the animals declined mar­
kedly. The mortality rates of the various groups between 360 and 500 days, based on those alive at 360 
days, are given in Table II. 
Evaluation by a chi square test with 9 degrees of freedom gave a value of 16.6 (P<—0.05) 
suggesting that differences between the animals with high and low mortality were real. 
TABLE I 
Fatty Acid Composition of Coconut Oil 
Chain 
length 
Chain
 0 / Chain 
length " length % 
6 : 0 
8 :0 
10 : 0 
0.5 1 2 : 0 49.5 1 8 : 0 
6.5 1 4 : 0 19.5 1 8 : 1 
6.0 1 6 : 0 8.5 1 8 : 2 
2.0 
6.0 
1.5 
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Data as to. terminal histopathologic^ findings in coconut oil-fed animals supplied with essential 
fatty acids are particularly scarce. In one such study, no differences between animals fed coconut oil or 
butter were noted (21). 
Considerably more is known about the digestibility of coconut oil in men. It is nearly completely 
absorbed as are most other natural dietary fats (22-24). stools of children were the same after the feeding 
of coconut oil or milk fat (25). The growth rale of animals fed coconut oil has frequently been compared 
to that of controls fed butter or other natural dietary fats. No major differences have been reported 
(24, 26-28). 
Coconut oil, like other fats, exerts a strong influence on the composition of the body's triglyce­
rides especially those of the depot fat (26). Predictable changes in the composition of the depot fat could 
be recognized one week after feeding had started (29). When randomized saturated medium chain trigly 
cerides (MOT) derived from coconut oil were fed to rats (30) the resulting depot fat contained above" 
50% laurate and myristate. 
Coconut oil contains only 2-3% linoleate; it shares such a low linoleate content with olive oil 
(the second of the time-honored vegetable oils) and with milk fat, the most specific mammalian fat. One 
may theorize that the relatively low linoleate content of coconut oil and olive oil not only protects these 
fats from rapid rancidification but offers other (evolutionary?) advantages, a speculation suggested by 
the low linoleate content of milk fat. Modern vegetable oils may contain about 50% linoleate or high 
percentages of linolenic or eleostearic acid. 
When the physical properties of coconut oil are changed by hydrogenation, it becomes more 
suitable for margarine production; therefore, mainly hydrogenated coconut oil containing at best 0.5% 
linoleate has been used for nutritional experiments during the last decades. 
Coconut oil intake is associated with high linoleate requirements which can be concluded from 
the observation that deficiency signs occur early after the start of feeding (31). In view of this finding, 
it is of interest that the essential fatty acid requirements of rats fed MCT compared to those of rats main­
tained on saturated long chain (palmitate and stearate) triglycerides were higher in the latter group. 
At the same time, the linoleate content of the epididymal fat of the animals fed the longer chains was 
higher than that of the animals fed MCT (30). Rats fed hydrogenated coconut oil behave like those given 
triglycerides with longer chains because it was noted that feeding of hydrogenated coconut oil was asso­
ciated with higher values of tissue linoleate (32). This emphasizes the higher linoleate requirements of 
animals fed hydrogenated coconut oil. 
These observations probably explain a number of seemingly contradictory findings. It is obvious 
that the absence of an essential dietary element, such as essential fatty acids, produces deficiency symp­
toms. Comparisons of the effects of hydrogenated coconut oil with those produced by other fats should 
only be made if the diets contain all essential elements including essential fatty acids; otherwise animals 
having a deficiency disease are compared to controls. The violation of this principle greatly limits the con­
clusions which can be drawn from many studies. Thus, histological lesions were noted in rats fed hydro­
genated coconut oil without essential fatty acids over a protracted period (33). The authors concluded 
that saturated fats were the cause of the lesions. However, it seems more probable that the lesions were 
due to the induced linoleate deficiency. Similar objections must be raised to a study in which the effects 
of alternately feeding rabbits 40% corn oil and 40% hydrogenated coconut oil were compared to effects 
in controls receiving a mixture of 20% of each. The animals receiving only hydrogenated coconut oil for 
TABLE II 
Mortality Rates of Male Rates Fed Various Fats 
Fat 
No. of 
Animals Fat 
No. of 
Animals % 
Cottonseed oil 15/80 19 Corn oil 7/77 9 
Olive oil 10/78 13 Lard 7/79 8 
Chicken fat 9/77 12 MCT (40 in group) 3/37 8 
Soybean oil 8/78 10 Coconut oil 5/63 8 
Butter 8/78 10 Beef fat 3/80 4 
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periods of 10 weeks were on diets deficient in an essential dietary element but the controls werenot (34). 
These two papers have been singled out of many for a more detailed discussion because of the great 
care with which the experiments had been carried out. 
Conditions are further complicated by the fact that the essential fatty acid requirements are also 
enhanced by the use of highly purified diets but the nature of the protective effect of diets made up of 
natural food stuffs (laboratory chow) has not been identified (35). 
All of this has an important bearing on the discrepancies one encounters in the literature about 
the calcium metabolism of experimental animals fed coconut oil. When a rachitogenic diet made up of 
natural food stuffs was fed to rats, the inclusion of coconut oil had antirachitic properties; it improved the 
quality of the damaged bones (36,37). When rachitogenic diets composed of purified materials including 
refined coconut oil were fed, negative Ca balances with reduced utilization of Ca were noted (28,38,39). 
Some of these contradictions could be explained by the outcome of the above discussed experi­
ment with male rats of the Charles River strain. Seventeen of 80 rats (21 %) supplied with coconut oil 
containing 2.5 % of a linoleate concentrate died during the first year of observation whereas Only 3 % of 
the rats fed other fats died. Autopsy findings (gross and histological) on the. dead animals fed coconut 
oil have revealed the presence of advanced secondary hyperparathyroidism in three of the 17 animals 
so far examined. The renal insufficiency which is the basic cause of this condition is associated with phos­
phorus retention, causing hypocalcemia; this in turn stimulates the parathyroid glands which hyper­
trophy and excrete large amounts of parathormone leading to calcium mobilization from the bones and 
widespread calcification of organs. This disturbance of Ca metabolism is frequent among old rats but was 
not seen in animals fed other fats below the age of 500 days. When the linoleate level of the animals 
fed coconut oil was raised, the death rate was reduced and no gross symptoms of secondary hyperpara­
thyroidism were observed in the animals dying from that time up to the age of at least 500 days. 
Therefore, this disturbance of Ca metabolism was somehow related to essential fatty acid deficiency, 
which may also have played a part in experiments in which adverse effects of hydrogenated coconut oil 
have been noted. Further work about the properties of bones of animals fed coconut oil is desirable. 
No topic related to coconut oil has been given more prominence than its relation to cholesterol 
metabolism in mammals. 
Whether or not human societies consuming large amounts of coconut oil develop more or less 
arteriosclerosis than other societies and whether any differences are due to the fats consumed can not 
be answered with any degree of certainty. 
However, it has been claimed that the inhabitants of Thailand have a low rate of heart attacks 
and strokes although coconut oil is their leading dietary fat (40). In a study on two groups of Polynesians, 
it was found that the group eating 89 % of their fat as coconut oil had lower blood pressure values than 
those eating 7%. Heart attacks were not observed in either group. There were, of course, many other 
differences between the groups (41). In another study on Polynesians, it was found that Pukapukans 
consuming large amounts of coconut oil had lower serum cholesterol levels and a lower incidence of arte­
riosclerosis than the Maoris (and Europeans) who consumed a- European type of diet (42). 
During the fifties, it was established that the intake by humans of ethyl linoleate or of vegetable 
oil containing large amounts of linoleate reduced serum cholesterol levels (43,44); this was true especially 
when liquid formula diets were used. The subsequent feeding of the same formula diet, but containing 
coconut oil, raised the level of serum cholesterol although not to the level previous to the intake of the 
liquid diet (45). At the same time, it was noted that the effect given by coconut oil was less pronounced 
than had been anticipated from its saturation (46). 
Other observations about the effect, in man, of coconut oil on lipid metabolism include the obser­
vation that alimentary lipemia is less pronounced after the intake of coconut oil than after consumption 
of other fats (47, 48) and that coconut oil containing 5% of safflower oil, when added to the standard 
diet of inmates of a mental institution, reduced serum cholesterol levels (49). 
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Coconut oil has been used in a vast number of animal studies concerned with the pathogenesis 
of vascular lesions. The magnitude of this work is such that one can, at best, hope to recognize a few 
general principles. 
The experimental work can roughly be divided into three categories: (a) studies in which coconut 
oil was fed in the presence of a sufficient supply of essential fatty acids; (b) studies in which hydroge­
nated coconut oil was supplied without additional fatty acids; (c) studies in which hydrogenated coconut 
oil was part of essential fatty acid deficient diets to which cholesterol had been added. This latter category 
constitutes the majority of the reports. 
When coconut oil was fed to animals as a constituent of diets made of natural food stuffs, tissue 
lesions and serum and tissue cholesterol levels hardly differed from those found with many other natural 
dietary fats. Thus, rabbits maintained on laboratory chow supplemented with hydrogenated coconut oil, 
hydrogenated vegetable oil, or butter showed no arterial lesions after one year (SO). Rabbits maintained 
on laboratory stock diets and given daily supplements of 5 cc of hydrogenated coconut oil, cottonseed 
oil, or peanut oil showed no effect on serum cholesterol levels after nine weeks (SI). Rhesus monkeys 
eating a normal diet supplemented with coconut, mustard and sesame oils for nine months showed the 
lowest aortic cholesterol values in the coconut oil fed animals (52). 
When purified, essential fatty acid deficient diets containing hydrogenated coconut oil were used, 
the results were so strongly influenced by species, age, previous diet, etc. that it is hardly possible lo arrive 
at a common denominator. In the careful study discussed above rabbits developed widespread histopa-
thological changes (including some in the arteries) after one year. In other species it was more difficult 
to produce histological lesions. Thus, growing chicks given a low fat diet supplemented with coconut, 
corn, or olive oil showed no differences in plasma and aortic cholesterol (53). Dogs are quite immune to 
the induction of vascular changes by an essential fatty acid deficient hydrogenated coconut oil diet unless 
the deficiency state is compounded by the induction of hypothyroidism (54). One strain of pigeons 
developed coronary lesions on the essential fatty acid deficient diet containing hydrogenated coconut 
oil (55). When two chimpanzees were given a purified essential fatty acid deficient diet containing hydro­
genated coconut oil, one developed vascular lesions exceeding those of the controls (56). 
It has been demonstrated again and again that essential fatty acid deficient diets with added choles­
terol will eventually induce lesions of the coronary arteries regardless of the origin of the usually hydro­
genated fat. This has been found in various birds and is probably true for all mammaliam species. The 
amounts of cholesterol which the animals are forced to eat are unphysiological; they lead to cholesterol 
deposits in various organs especially the RES before the coronary arteries are visibly involved. Whether 
or not results obtained by inducing a deficiency state and an unphysiological dietary stress are relevant to 
human arteriosclerosis is questionable. The fact that the histological appearance of some of the vascular 
lesions produced in animals has some resemblance to human arteriosclerotic lesions is probably of no 
etiological significance because of the limited response potential of arteries to any chronic injuries. How­
ever, there is a need for well controlled long term experiments with primates in which the effects of various 
dietary fats are compared under mote physiological conditions. 
The medium chain saturated acids of coconut oil have been reconstituted into randomized trigly­
cerides (MCT). Feeding of one of these mixtures containing predominantly C 9 and C6 acids beneficially 
modified the effects of various stress conditions under which rats had been kept (4). Related studies have 
been carried out with coconut oil in deficiency states, in disturbances of carbohydrate metabolism, in 
infections, and with cancerogenic substances. 
It was found that the signs of vitamin B deficiency in rats could be diminished when coconut oil 
was added to the diet (10). The deficiency signs developed by young calves fed a fat free diet could be 
prevented by 2 % of coconut oil while 4 % of lard was necessary to give the same effect (57). 
Some of the metabolic effects of MCT simulate those of carbohydrates(5). This metabolic behavior 
of medium chain fatty acids may explain that feeding of hydrogenated coconut oil to rats tends to increase 
their liver glycogen (58). Similarly it was rioted that, in rats fed laboratory chow and given various 
fats by stomach tube, liver glycogen was highest in animals fed hydrogenated coconut oil (59). This may 
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have some bearing on the observation that the diabetogenic action of aloxan in lard-fed rats was counter­
acted by coconut oil (60). However, disturbances of glucose tolerance and diminished liver glycogen were 
noted in rabbits fed 25 % of saturated fats such as hydrogenated coconut or peanut oils in essential fatty 
acid deficient diets (61). 
Injection of extracts of coconut milk seemed to retard experimental tuberculosis in mice (62); 
this may be related to the finding that feeding of coconut oil as compared to olive and linseed oil retaided 
experimental tuberculosis in mice (63). 
Numerous studies have been reported about the development of liver tumors in experimental 
animals fed carcinogenic azo dyes in diets containing various fats. Feeding of coconut oil (and of laurate) 
was associated with lower tumor incidence (64). In the cited experiment with Charles River rats, chlcro-
matous leukemia, frequently noted in rats fed other fats, was not seen in those given coconut oil or MCT. 
Finally it deserves to be mentioned that, in rats, re-establishment of normal spleen after whole 
body irradiation was facilitated by feeding of coconut oil (65). 
It seems permissible to conclude that intake of coconut oil as part of a mixed diet containing 
enough essential fatty acid has evidently no disadvantages and may have some advantages. 
We have pointed out that all dietary fats have their individual properties which cannot be explai­
ned by any single chemical characteristic. The example of coconut oil shows how useless and misleading 
it is from a nutritional standpoint, to classify a particular fat simply as saturated. 
There is a great need for long term nutritional studies with coconut oil and other dietary fats 
especially in primates although their long life span (compared to rodents) makes the execution of such 
studies by young researchers mandatory. Desirable levels of essential fatty acid in hydrogenated coconut 
oil will have to be established taking into consideration that not only low levels but also too high ones 
may be disadvantageous. The nature of the materials responsible for relatively lower essential fatty 
acid requirements in diets made of natural food stuffs needs attention. Finally, and perhaps most impor­
tant, more work is necessary to establish why a variety of stress conditions were found to be beneficially 
influenced by MCT and coconut oil. 
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